Nephros (NEPH) Investor Presentation - Slideshow

Company Overview - Nephros is a commercial-stage medical device company focused on liquid purification filters and hemodiafiltration systems for end-stage renal disease patients[5] - The company's strategy prioritizes the large, fast-growing medical device sector[9, 74] - Insider ownership accounts for 50% of the company[4] Financial Performance - The company has demonstrated 10 consecutive quarters of growth, averaging 55% year-over-year[9, 74] - Gross margins are consistently between 55% and 60%[9, 74] - 2017 revenue was $3.8 million, and 2018 revenue reached $5.7 million[4] - Cash on hand as of December 31, 2018, was $4.5 million[4] Products and Markets - The total addressable market for water ultrafiltration products is over $1 billion[20] - The company is launching a pathogen diagnostic product to complement its medical device offerings[9, 74] - Nephros ultrafilters have a pore size 40 times smaller than conventional filters[27]